ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,493Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 1499

$1.13M Total Retail Price of All Prescriptions

Rank: 54 out of 1499

783 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 783 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

26% of this provider’s 783 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 16,338 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCODONE-ACETAMINOPHEN 1,064 602 S3 1 4
FUROSEMIDE 787 646 2 7
WARFARIN SODIUM 735 652 3 12
POTASSIUM CHLORIDE 698 607 4 11
LEVOTHYROXINE SODIUM 659 558 5 2
OMEPRAZOLE 591 446 6 5
LISINOPRIL 540 403 7 1
AMLODIPINE BESYLATE 390 312 8 6
GABAPENTIN 384 277 9 13
RANITIDINE HCL 373 235 10 15
CITALOPRAM HBR 360 258 11 14
METFORMIN HCL 329 207 12 8
METOPROLOL TARTRATE 316 223 13 10
SIMVASTATIN 304 244 14 3
PREDNISONE 288 189 15 42
DONEPEZIL HCL 276 233 16 35
CARVEDILOL 275 218 17 22
CEPHALEXIN 267 191 18 83
LANTUS 237 215 19 46
ZOLPIDEM TARTRATE 232 156 20 23
FLUOXETINE HCL 212 155 21 43
MELOXICAM 201 132 22 27
CLONIDINE HCL 186 156 23 57
HYDROCHLOROTHIAZIDE 185 122 24 9
ATORVASTATIN CALCIUM 185 129 24 17
NEXIUM 181 98 26 28
ATENOLOL 180 110 27 21
FENTANYL 178 126 S2 28 60
CARBIDOPA-LEVODOPA 173 133 29 92
PANTOPRAZOLE SODIUM 171 140 30 48
NAMENDA 167 149 31 47
DIGOXIN 166 160 32 56
CYCLOBENZAPRINE HCL 165 61 R 33 41
POLYETHYLENE GLYCOL 3350 163 131 34 52
TAMSULOSIN HCL 156 137 35 29
SPIRONOLACTONE 153 128 36 61
CYMBALTA 152 80 37 40
CIPROFLOXACIN HCL 149 112 38 65
DILTIAZEM 24HR CD 149 107 38 82
QUETIAPINE FUMARATE 148 147 40 72
ISOSORBIDE MONONITRATE ER 147 113 41 51
LOVASTATIN 142 116 42 19
TRAMADOL HCL 141 81 43 16
MIRTAZAPINE 127 105 44 50
TRAZODONE HCL 126 85 45 32
OLANZAPINE 126 100 45 140
CLOPIDOGREL 116 86 47 39
METOPROLOL SUCCINATE 115 101 48 20
METOCLOPRAMIDE HCL 115 83 48 114
ROPINIROLE HCL 107 76 50 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 71 51 87
AMITRIPTYLINE HCL 103 56 R 52 49
FLUTICASONE PROPIONATE 102 81 53 31
TRIAMTERENE-HCTZ 101 43 54 62
MUPIROCIN 100 88 55 177
SUCRALFATE 98 69 56 213
NOVOLOG 97 88 57 110
DIOVAN 96 96 58 58
HUMALOG 96 84 58 193
LANTUS SOLOSTAR 94 50 60 89
LOSARTAN POTASSIUM 93 86 61 26
OXYCODONE HCL-ACETAMINOPHEN 92 0 S2 62 81
CRESTOR 91 71 63 34
SERTRALINE HCL 91 67 63 24
AZITHROMYCIN 90 75 65 45
OXYBUTYNIN CHLORIDE 89 76 66 95
DICYCLOMINE HCL 85 69 67 181
NYSTATIN 84 73 68 146
BACLOFEN 84 26 68 119
ADVAIR DISKUS 80 76 70 37
RISPERIDONE 80 56 70 74
OXYCODONE-ACETAMINOPHEN 79 46 S2 72 80
FAMOTIDINE 78 66 73 86
ENDOCET 77 18 S2 74 111
GLIPIZIDE ER 77 77 74 129
SPIRIVA 75 74 76 44
OXYCODONE HCL 73 27 S2 77 79
ALLOPURINOL 71 45 78 36
PLAVIX 70 54 79 54
LIDODERM 70 50 79 123
OXYCONTIN 70 20 S2 79 99
PROMETHAZINE HCL 69 49 R 82 138
PREMARIN 68 34 R 83 139
PRAVASTATIN SODIUM 67 56 84 18
ZETIA 67 67 84 91
THEOPHYLLINE ANHYDROUS 66 38 86 238
ESTRADIOL 65 15 R 87 130
ESCITALOPRAM OXALATE 63 49 88 76
HYDROXYZINE HCL 63 28 R 88 173
TRICOR 62 26 90 103
DIVALPROEX SODIUM ER 62 30 90 153
SANTYL 61 54 92 260
FLUCONAZOLE 61 40 92 190
METOLAZONE 61 40 92 174
CARISOPRODOL 57 25 R 95 71
SEROQUEL 56 52 96 158
NYSTOP 56 49 96 208
LIPITOR 55 42 98 107
TIZANIDINE HCL 55 23 98 105
ABILIFY 55 27 98 143
GLIMEPIRIDE 55 43 98 38
CLOTRIMAZOLE-BETAMETHASONE 55 46 98 201
NYSTATIN-TRIAMCINOLONE 54 29 103 229
NITROFURANTOIN MONO-MACRO 53 52 104 188
MIDODRINE HCL 52 44 105 384
AMITIZA 51 36 106 326
PHENYTOIN SODIUM EXTENDED 51 25 106 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.